In summary, the A5/158-vc-MMAE ADC specifically kills Endo180-expressing cell lines, causes regression of an Endo180-positive osteosarcoma tumor model, and reduces metastatic colonization of the lung, liver, and lymph nodes. Here, MRC2 is linked to neoplasm.